Higher Glycemic Index and Glycemic Load Diet Is Associated with Slower Disease Progression in Amyotrophic Lateral Sclerosis
Authors:
- 29 November 2023
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 95 (2) , 217-229
Abstract
Objective: High‐caloric diets may slow the progression of amyotrophic lateral sclerosis; however, key macronutrients have not been identified. We examined whether dietary macronutrients are associated with the rate of progression and length of survival among the prospective cohort study participants.Methods: Participants with a confirmed diagnosis of sporadic amyotrophic lateral sclerosis enrolled in the Multicenter Cohort Study of Oxidative Stress were included (n = 304). We evaluated baseline macronutrient intake assessed by food frequency questionnaire in relation to change in revised amyotrophic lateral sclerosis functional rating scale total‐score, and tracheostomy‐free survival using linear regression and Cox proportional hazard models. Baseline age, sex, disease duration, diagnostic certainty, body mass index, bulbar onset, revised amyotrophic lateral sclerosis functional rating scale total‐score, and forced vital capacity were included as covariates.Results: Baseline higher glycemic index and load were associated with less decline of revised amyotrophic lateral sclerosis functional rating scale total score at 3‐month follow‐up (β = −0.13, 95% CI −0.2, −0.01, p = 0.03) and (β = −0.01, 95% CI −0.03, −0.0007, p = 0.04), respectively. Glycemic index second‐quartile, third‐quartile, and fourth‐quartile groups were associated with less decline at 3 months by 1.9 (95% CI −3.3, −0.5, p = 0.008), 2.0 (95% CI −3.3, −0.6, p = 0.006), and 1.6 (95% CI −3.0, −0.2, p = 0.03) points compared with the first‐quartile group; the glycemic load fourth‐quartile group had 1.4 points less decline compared with the first‐quartile group (95% CI −2.8, 0.1, p = 0.07). Higher glycemic index was associated with a trend toward longer tracheostomy‐free survival (HR 0.97, 95% CI 0.93, 1.00, p = 0.07).Interpretation: Higher dietary glycemic index and load are associated with slower disease progression in amyotrophic lateral sclerosis. ANN NEUROL 2024;95:217–229Keywords
Funding Information
- American Academy of Neurology
- American Brain Foundation
- Muscular Dystrophy Association
- National Institute of Environmental Health Sciences (R01ES016348)
- National Institute of Neurological Disorders and Stroke (K23NS131586)
This publication has 71 references indexed in Scilit:
- Glucose delays age‐dependent proteotoxicityAging Cell, 2012
- A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral SclerosisPLOS ONE, 2012
- Continuous glucose monitoring to assess the ecologic validity of dietary glycemic index and glycemic loadThe American Journal of Clinical Nutrition, 2011
- Beneficial vascular risk profile is associated with amyotrophic lateral sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2011
- Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosisMuscle & Nerve, 2011
- Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patientsJournal of Neurology, Neurosurgery & Psychiatry, 2010
- Prognostic factors in ALS: A critical reviewAmyotrophic Lateral Sclerosis, 2009
- High metabolic level in patients with familial amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis, 2009
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- Validation of a self-administered diet history questionnaire using multiple diet recordsJournal of Clinical Epidemiology, 1990